Fox Run Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-6,441
Closed -$533K 925
2018
Q2
$533K Buy
+6,441
New +$533K 0.17% 218
2017
Q3
Sell
-9,400
Closed -$562K 962
2017
Q2
$562K Sell
9,400
-8,300
-47% -$496K 0.19% 184
2017
Q1
$944K Buy
+17,700
New +$944K 0.39% 26